Identification of CYP2C9 and VKORC1 polymorphisms in Iranian patients who are under warfarin therapy.

Poopak, Behzad; Rabieipoor, Saghar; Safari, Nazila; Naraghi, Emadedin; Sheikhsofla, Fatemeh; Khosravipoor, Gelareh.

Afiliação

Poopak B; DCLS, PhD in Hematology, Islamic Azad University, Tehran Medical Sciences Branch, Tehran, Iran.
Rabieipoor S; MSc in Biotechnology, Payvand Clinical and Specialty Laboratory, Tehran, Iran.
Safari N; MSc in Molecular Oncology, Payvand Clinical and Specialty Laboratory, Tehran, Iran.
Naraghi E; MSc in Bioscience, Payvand Clinical and Specialty Laboratory, Tehran, Iran.
Sheikhsofla F; MSc in Cell and Molecular Biology, Payvand Clinical and Specialty Laboratory, Tehran, Iran.
Khosravipoor G; MD, Payvand Clinical and Specialty Laboratory, Tehran, Iran.

Int J Hematol Oncol Stem Cell Res ; 9(4): 185-92, 2015 Oct 01.

Article em En | MEDLINE | ID: mdl-26865929